Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

A scoping review of breakthrough cancer pain: mapping the evidence landscape.
(2026 Mar 7)
Support Care Cancer 34(4):
Davis M, Portenoy R, Davies A, Mercadante S, Reddy A, Rajagopal MR, Bruera E

Psychometric Evaluation of the FFOCI-SF and Other Clinical Outcome Measures in a Group Therapy for Overcontrol (Group Radical Openness).
(2026 Mar)
Int J Methods Psychiatr Res 35(1): e70069
Twomey C, Nelson-Sisinni A

Key Factors for Quality End-of-Life Care for People With Intellectual Disabilities. A Critical Interpretive Synthesis Review Using a 'Best-Fit' Framework Approach.
(2026 Mar)
J Appl Res Intellect Disabil 39(2): e70208
Haigh M, McCallion P, McCarron M, Pavithra P, McMahon M

Combined Oral Contraceptive Drug-Drug Interaction Study With Ganfeborole, a New Anti-Tuberculosis Agent.
(2026 Mar)
J Clin Pharmacol 66(3): e70161
Iavarone L, Lavezzi SM, Carcas AJ, Chaychenko T, Gabarro-Carrion R, Huertas AGLL, Gresham S, Marín-Candón A, Penman SL, Rolfe K, Tiberi S, Barros-Aguirre D, Borobia AM, ERA4TB consortium

Translation of expanded CGG repeats in LRP12 associated oculopharyngodistal myopathy.
(2026 Mar 6)
Acta Neuropathol Commun
Li C, Daw JA, Pittman SK, Maltby CJ, Sakurai H, Todd PK, Weihl CC

Show complete publication list

In the News